Skip to content
LinkeWire
  • Home
  • Submit Your Article
  • Blog
  • About Us

Biogen

Cognizance Market Research

Global Amyotrophic Lateral Sclerosis Market to Reach US$1.11 Billion by 2030, Driven by Novel Therapies and Rising R&D Investment

June 1, 2025 by Cognizance Market Research

Amyotrophic lateral sclerosis formerly known as Lou Gehrig’s disease, is a neurological disorder that affects motor neurons, the nerve cells in the brain and spinal …

Read More

Categories News Tags ALS treatment, Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis Market, Biogen, Clinical Trials, Gene Therapy, Ionis Pharmaceuticals, Lou Gehrig's disease, Mitsubishi Tanabe Pharma, motor neuron disease, Neurological Disorders, Orphan Drugs, QALSODY (tofersen), Sanofi
Primary Progressive Multiple Sclerosis Treatment Market

Global Primary Progressive MS Treatment Market to Reach US$3.01 Billion by 2030, Driven by New Drug Approvals and Rising Diagnosis Rates

May 27, 2025 by Cognizance Market Research

Primary Progressive Multiple Sclerosis (PPMS) is a kind of MS that affects around 15% of all MS patients. PPMS, unlike other types of MS, is …

Read More

Categories News Tags Biogen, Clinical Trials, demyelinating diseases, Genzyme, MS therapy, multiple sclerosis, Neurological Disorders, Novartis, ocrelizumab, PPMS treatment, Primary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Treatment Market, Roche, Siponimod

Reach out to us for a consultation.

Let’s work together to start moving your business in the right direction.

Contact Us

© Linkewre

Privacy Policy Refund Policy Terms & Condition
  • Home
  • Submit Your Article
  • Blog
  • About Us